Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0HMXA | ISIN: FR0010095596 | Ticker-Symbol: C4X
Frankfurt
06.06.25 | 08:04
0,050 Euro
-22,36 % -0,014
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
VALERIO THERAPEUTICS Chart 1 Jahr
5-Tage-Chart
VALERIO THERAPEUTICS 5-Tage-Chart
RealtimeGeldBriefZeit
0,0640,06617:18

Aktuelle News zur VALERIO THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.05.Valerio Therapeutics S.A.: Valerio Therapeutics: Postponement of 2024 Annual Financial Report Publication and the Approval of Financial Statements265Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) (the "Company") announces the postponement of the publication of its 2024 annual financial report, initially scheduled...
► Artikel lesen
11.04.XFRA CAPITAL ADJUSTMENT INFORMATION - 11.04.2025273Das Instrument J1X BMG4660A1036 HIMALAYA SHIPPING LTD DL1 EQUITY wird cum Kapitalmassnahme gehandelt am 11.04.2025 und ex Kapitalmassnahme am 14.04.2025 The instrument J1X BMG4660A1036 HIMALAYA SHIPPING...
► Artikel lesen
19.03.VALERIO THERAPEUTICS: List of the Board Members Positions Held in Other Companies as of March 19, 2025257Regulatory News: VALERIO THERAPEUTICS (Paris:ALVIO): Name of Director Other offices and functions Julien MIARA Chief Executive Officer and Director ...
► Artikel lesen
19.03.Valerio Therapeutics: Report of the Board of Directors296To the Ordinary and Extraordinary Shareholders' General Meeting of April 9, 2025 Regulatory News: Valerio Therapeutics (Paris:ALVIO): Ladies and Gentlemen, We have convened this General...
► Artikel lesen
03.03.Valerio Therapeutics Announces the Termination of the Liquidity Contract Entered Into on 29 October 2018 With KEPLER CHEUVREUX295Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) (the 'Company') announces that it has terminated the liquidity agreement entered into on 29 October 2018 with KEPLER...
► Artikel lesen
VALERIO THERAPEUTICS Aktie jetzt für 0€ handeln
07.02.Kepler cuts Valerio Therapeutics stock rating amid trials halt2
04.02.Valerio Therapeutics Announces Strategic Refocus288Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) today announced a strategic decision to discontinue all clinical trials and associated activities, including the ongoing...
► Artikel lesen
15.11.24Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024263Regulatory News: At its meeting of November 13, 2024, the Board of Directors of Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), ("Valerio Therapeutics" or the "Company") decided to appoint...
► Artikel lesen
30.09.24Valerio Therapeutics S.A.: Valerio Therapeutics Reports its Half-Year 2024 Financial Results and Provides an Update on its Activities466Acquisition of Emglev Therapeutics to focus on discovering single-domain antibodies (sdAbs) The VIO-01 trial is currently in Phase 1 dose escalation R&D efforts maintained for optimization...
► Artikel lesen
30.09.24Valerio Therapeutics S.A.: Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company486Valerio Therapeutics acquires Emglev Therapeutics, a single-domain antibody-based therapeutics company The transaction was completed on September 29, 2024, enabling the acquisition of Emglev's...
► Artikel lesen
05.08.24Half-Year Liquidity Contract Statement for Valerio Therapeutics385 Regulatory News: Under the liquidity contract entered into between VALERIO THERAPEUTICS (Paris:ALVIO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30...
► Artikel lesen
11 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1